<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>pharmaceutical Archives - UK Investor Magazine</title>
	<atom:link href="https://ukinvestormagazine.co.uk/tag/pharmaceutical/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/tag/pharmaceutical/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Mon, 17 Feb 2025 00:28:17 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>

<image>
	<url>https://ukinvestormagazine.co.uk/wp-content/uploads/2025/05/cropped-favicon-96-96-32x32.jpg</url>
	<title>pharmaceutical Archives - UK Investor Magazine</title>
	<link>https://ukinvestormagazine.co.uk/tag/pharmaceutical/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>ASX-listed Wellnex Life set to join AIM</title>
		<link>https://ukinvestormagazine.co.uk/asx-listed-wellnex-life-set-to-join-aim/</link>
					<comments>https://ukinvestormagazine.co.uk/asx-listed-wellnex-life-set-to-join-aim/#comments</comments>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Mon, 17 Feb 2025 00:28:16 +0000</pubDate>
				<category><![CDATA[IPO Analysis]]></category>
		<category><![CDATA[Premium]]></category>
		<category><![CDATA[Shares]]></category>
		<category><![CDATA[UK Investor Vantage]]></category>
		<category><![CDATA[ASX]]></category>
		<category><![CDATA[Haleon Group]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Wellnex Life Ltd]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=78795</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Alliance-Pharma-pretax-profit-surge-22-3-22-1-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" fetchpriority="high" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Alliance-Pharma-pretax-profit-surge-22-3-22-1-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Alliance-Pharma-pretax-profit-surge-22-3-22-1-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Alliance-Pharma-pretax-profit-surge-22-3-22-1-150x100.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Alliance-Pharma-pretax-profit-surge-22-3-22-1-600x400.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Alliance-Pharma-pretax-profit-surge-22-3-22-1-696x464.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Alliance-Pharma-pretax-profit-surge-22-3-22-1-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2022/03/Alliance-Pharma-pretax-profit-surge-22-3-22-1.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>ASX-listed consumer healthcare company Wellnex Life Ltd (ASX: WNX) is planning to gain an additional quotation on AIM. It currently has a market capitalisation of A$20m. The company was originally a dairy products business but subsequently moved into consumer healthcare. This has been the focus since 2021. Wellnex Life has an agreement with Haleon to [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/asx-listed-wellnex-life-set-to-join-aim/">ASX-listed Wellnex Life set to join AIM</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/asx-listed-wellnex-life-set-to-join-aim/feed/</wfw:commentRss>
			<slash:comments>15</slash:comments>
		
		
			</item>
		<item>
		<title>Novo Nordisk UK announces no-deal Brexit contingency plan</title>
		<link>https://ukinvestormagazine.co.uk/novo-nordisk-uk-announces-no-deal-brexit-contingency-plan/</link>
					<comments>https://ukinvestormagazine.co.uk/novo-nordisk-uk-announces-no-deal-brexit-contingency-plan/#respond</comments>
		
		<dc:creator><![CDATA[Dina Caruso]]></dc:creator>
		<pubDate>Wed, 05 Sep 2018 09:49:17 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Brexit]]></category>
		<category><![CDATA[Denmark]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[Novo Nordisk]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=13868</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2018/09/Novo-Nordisk-UK-announces-no-deal-Brexit-contingency-plan--300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2018/09/Novo-Nordisk-UK-announces-no-deal-Brexit-contingency-plan--300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/09/Novo-Nordisk-UK-announces-no-deal-Brexit-contingency-plan--768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/09/Novo-Nordisk-UK-announces-no-deal-Brexit-contingency-plan--630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/09/Novo-Nordisk-UK-announces-no-deal-Brexit-contingency-plan--537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/09/Novo-Nordisk-UK-announces-no-deal-Brexit-contingency-plan--640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/09/Novo-Nordisk-UK-announces-no-deal-Brexit-contingency-plan--681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/09/Novo-Nordisk-UK-announces-no-deal-Brexit-contingency-plan-.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Novo Nordisk UK (CPH:NOVO-B) has announced it is building up a four-month stock-pile in the event of a no-deal Brexit. The Danish company is taking this action in order to ensure patients’ insulin supply remains unaffected in the event of a no-deal Brexit. The global pharmaceutical company founded in 1923 has its headquarters in Denmark. [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/novo-nordisk-uk-announces-no-deal-brexit-contingency-plan/">Novo Nordisk UK announces no-deal Brexit contingency plan</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/novo-nordisk-uk-announces-no-deal-brexit-contingency-plan/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
